• Join Vera Therapeutics for a virtual investor event featuring Jonathan Barratt, MD, PhD, FRCP (University of Leicester), along with Vera’s management…
    Join Senseonics for a virtual KOL event featuring David T. Ahn, MD (Hoag Medical Group) and Jeff Ciaramita, MD (Mercy), who will join company…
    Join Erasca for a virtual investor event where management will provide a research and development (R&D) update on naporafenib and…
    Join Pharvaris for a virtual investor event featuring Michael Manning, M.D. (Allergy, Asthma & Immunology, LTD) and Raffi Tachdjian, M.D.,…
    Join scPharmaceuticals for a KOL webinar focused on a nephrologist’s perspective on the use of FUROSCIX for treating fluid overload…
    Join Aura Biosciences for a virtual urologic oncology investor event featuring key opinion leaders (KOLs) Max Kates, MD (Brady Urological…
    Join Lipocine for a virtual KOL event featuring Frank Greenway, MD (Chief Medical Officer at Pennington Biomedical Research Center), who will discuss…
    Join Heidelberg Pharma for a virtual key opinion leader (KOL) event featuring Robert Z. Orlowski, MD, PhD (MD Anderson Cancer Center) and Shambavi…
    Join UNITY Biotechnology in-person or virtually for its 2024 Investor and Analyst Day, featuring presentations from prominent ophthalmology key opinion…
    Join GT Biopharma for a virtual KOL event featuring Jeffrey Miller, MD1 and Mark Juckett, MD from the University of Minnesota Medical School2, who…
    Join Valneva for a hybrid investor day in New York City, featuring speakers from company management, who will discuss the…
    Join Milestone Pharmaceuticals for Part 2 of its virtual investor education series featuring Aamer H. Jamali MD, FACC and Farhad Rafii, MD, FACC from…
    Join Arrowhead Pharmaceuticals for Part V of its 2024 Summer Series of R&D Webinars, featuring Jose Soria, MD (The Neuron Clinic). Arrowhead…
    Join Vera Therapeutics for an in-person and virtual R&D Day, featuring Jonathan Barratt, MD, PhD, FRCP (University of Leicester), Richard Lafayette,…
    Join Windtree Therapeutics for a virtual investor day featuring the new positive topline results of the Phase 2b SEISMiC Extension…
  • Positive Results and Design of Planned Phase 1b Study Recently Presented at the International Congress of Parkinson’s Disease and Movement…